Financial Performance Summary

FY26 Financials: The company reported a revenue of ₹318 crores for FY26, representing a 50% growth over FY25 revenue of ₹212 crores. EBITDA margins improved to 10% from 9% in FY25. PAT margins improved to 6% from 5% in FY25.

Volume Metrics: Sales volume for FY26 was 46,000 metric tons, up from 33,000 metric tons in FY25. This includes 4,400 metric tons from the company's own manufacturing capabilities.

H2 FY26 Performance: Revenue nearly doubled in the second half of FY26 compared to the first half. This was driven by a mix of increased volume and price escalation in raw materials, particularly from January 2026 onwards. The price increase led to a contraction in margins during the second half.

Operational and Capacity Highlights

Current Capacity: The total installed manufacturing capacity is 6,600 metric tons. Utilization is at 95% for the food and feed additives segments.

New Polymer Additives Plant: A new plant for halogen-free flame retardants has been set up with a capacity of 400 metric tons per month (4,800 MT annually). The plant is experiencing teething problems and is expected to be fully operational within the next 3-6 months. At an average selling price of ₹250 per kg, the plant has a potential revenue contribution of approximately ₹100 crores at 100% utilization.

Manufacturing vs. Trading: Currently, 23% of revenue comes from manufacturing activities, which yield a gross margin of 30%. The remaining 77% comes from trading activities (base oils, TG urea), which yield a gross margin of 21%. The long-term goal is to increase the manufacturing contribution to 50% of total revenue.

Expansion Plans and Capital Expenditure (CAPEX)

Land Acquisition: The company has acquired 9.6 acres of land for expanding its polymer additives and compounding facilities.

Phased Capacity Expansion: The plan is to scale total manufacturing capacity to 18,000 metric tons over the next 12-18 months.

CAPEX Outlay: A capital expenditure of ₹20 crores is planned for FY27 and FY28. This will be funded through a combination of internal accruals, unused IPO proceeds, and available bank credit lines.

Order Book and Business Pipeline

The current order book stands at ₹55 crores. This comprises ₹42 crores from government contracts (typically 6-month to 1-year duration) and ₹13 crores from private customers (typically quantity-based or 3-month contracts).

Working Capital and Cash Flow

The working capital cycle is currently 110 days. Management is focused on reducing this cycle to improve organizational cash flows. Strategies include invoice discounting facilities for buyers and negotiating supplier credit terms, though some large overseas suppliers still require 100% advance payment.

Research & Development (R&D) and Intellectual Property

R&D Team: The company has an 11-member R&D team, including three doctorates.

New Products: Products like Omega-3 and Vitamin D2 are in the R&D and industrial trial phase, with no confirmed commercialization timeline.

Patents: The company plans to file three patents related to its halogen-free flame retardant technology within the next six months.

Product and Market Strategy

Halogen-Free Flame Retardants: This is a new product line for the company, focusing on a blue ocean market in India with no direct competition for halogen-free variants. Initial target industries are wires & cables and electrical equipment, with future plans to target EV batteries.

The product's value proposition is based on safety, as it raises the ignition temperature and emits less toxic smoke compared to halogen-based alternatives.

Geopolitical Impact: While global scenarios disrupt import-based trading, they create an opportunity for the company's manufactured products as customers seek domestic alternatives.

Management Commentary and Forward-Looking Statements

Management expressed confidence in maintaining the company's growth momentum, citing its journey from ₹1 crore to over ₹300 crore in revenue. The expansion into polymer additives and the strategic shift towards higher-margin manufacturing are seen as key growth drivers for FY27 and beyond.

All forward-looking statements were qualified with standard disclaimers that actual results may differ materially from projections.